Skip to main content
Clinical Trials/NCT04778943
NCT04778943
Unknown
Not Applicable

Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spinal Stenosis

Tang-Du Hospital0 sites130 target enrollmentFebruary 28, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lumbar Spinal Stenosis
Sponsor
Tang-Du Hospital
Enrollment
130
Primary Endpoint
Oswestry Disability Index (ODI), , and Short Form-36 (SF-36) scores; discal and foraminal height; lumbar lordotic angle; and fusion status.
Last Updated
5 years ago

Overview

Brief Summary

The investigators will retrospectively study lumbar spinal stenosis patients who underwent OLIF or MIS-TLIF with percutaneous pedicle screw fixation between January 2016 and December 2019.The investigators will measure estimated blood loss, operative time, hospital stay, cost, reoperation, and complication incidence, visual analogue scale (VAS), Oswestry Disability Index (ODI), Japanese Orthopaedic Association (JOA), and Short Form-36 (SF-36) scores, discal and foraminal height, lumbar lordotic angle, and fusion status.The investigators will conduct to evaluate postoperative improvements, complications, and reoperation rates between patients with lumbar spinal stenosis (LSS) undergoing oblique lateral interbody fusion (OLIF) or minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).

Registry
clinicaltrials.gov
Start Date
February 28, 2021
End Date
March 29, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tang-Du Hospital
Responsible Party
Principal Investigator
Principal Investigator

Fei-Long Wei

Clinical Professor

Tang-Du Hospital

Eligibility Criteria

Inclusion Criteria

  • LSS due to neurogenic claudication; Central stenosis or lateral stenosis who need surgery; Single-level, low-grade (Meyerding grade 1 or 2) isthmic spondylolisthesis or degenerative spondylolisthesis; and imaging findings consistent with the symptoms of LSS.

Exclusion Criteria

  • trauma, active infection, malignant tumors, spinal deformity, previous lumbar fusion, multi-segment fusion, multi-level, high-grade (Meyerding grade 3 or 4) isthmic spondylolisthesis or degenerative spondylolisthesis.

Outcomes

Primary Outcomes

Oswestry Disability Index (ODI), , and Short Form-36 (SF-36) scores; discal and foraminal height; lumbar lordotic angle; and fusion status.

Time Frame: 2 Years

Before surgery and at the last follow-up, the following information was recorded

Secondary Outcomes

  • Japanese Orthopaedic Association (JOA)(2 Years)
  • visual analogue scale (VAS)(2 Years)
  • Short Form-36 (SF-36) scores(2 Years)
  • Major Complication rate(2 Years)

Similar Trials